FDA NDC Directory · JSON-LD · Markdown

Glipizide

NDC 70518-3645 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA203499
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsGLIPIZIDE (2.5 mg/1)
Marketing started20230216
Package count1

External sources

Source: openFDA. Public-domain (CC0).